The Honey Integrity Act directs the FDA to establish standards and enforcement mechanisms to protect the quality of honey sold in the United States. Within one year, the FDA must create an official definition of honey based on U.S. Pharmacopeia standards, and within two years must report to Congress on enforcement actions against adulterated or mislabeled honey. The bill creates a new "Honey Integrity Program" that requires commercial honey packers to test their products starting 180 days after enactment using advanced scientific methods like DNA testing and mass spectrometry to detect deliberate adulteration—such as dilution or ingredient substitution intended to deceive consumers. Packers must report test results to the FDA and alert authorities within 24 hours if they find adulterated honey, which they must refuse to sell. The FDA will work with U.S. Customs and Border Protection and the Department of Agriculture to investigate adulterated honey, share findings with law enforcement and industry groups, and maintain a public list of compliant packers. The program is funded through fees on commercial honey packers, with the specific amounts to be determined by the FDA and subject to congressional appropriation approval.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.